<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd">
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" width="781px" height="3211px" viewBox="-0.5 -0.5 781 3211" content="&lt;mxfile host=&quot;app.diagrams.net&quot; modified=&quot;2020-06-26T12:14:09.166Z&quot; agent=&quot;5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.116 Safari/537.36&quot; etag=&quot;enU-BiSctxJfGTnE5Dmg&quot; version=&quot;13.3.5&quot; type=&quot;github&quot;&gt;&lt;diagram id=&quot;8JQaeR7ikDl0GVS66GYh&quot; name=&quot;Page-1&quot;&gt;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&lt;/diagram&gt;&lt;/mxfile&gt;" resource="https://app.diagrams.net/?src=about#HMedeler%2Fhtml%2Fmaster%2Fpdf%2Fsvg%2F155_tuberculose.svg"><defs/><g><rect x="20" y="1760" width="760" height="480" fill="none" stroke="#000000" pointer-events="all"/><rect x="20" y="2360" width="760" height="850" fill="none" stroke="#000000" pointer-events="all"/><rect x="428" y="2380" width="352" height="120" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 345px; height: 1px; padding-top: 2387px; margin-left: 435px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Le <b>suivi </b>comprend :</div><div><ul><li>clinique, RXT, bactério jusqu'à négativation</li><li>vision couleurs mensuel pendant ttt EMB</li><li>bilan hépatique</li><ul><li>arrêt PZA si &gt; 3N</li><li>arrêt PZA et INH si &gt; 6N</li></ul></ul></div></div></div></div></foreignObject><text x="435" y="2399" fill="#000000" font-family="Karla" font-size="12px">Le suivi comprend :...</text></switch></g><rect x="98" y="2380" width="330" height="110" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 323px; height: 1px; padding-top: 2387px; margin-left: 105px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Le bilan <b>pré-thérapeutique</b> comprend :</div><ul><li>NFS, Na<sup>+</sup>, créat, bilan hépato-rénal, uricémie</li><li>séro VIH, VHB, VHC</li><li>examen ophtalmo + vision couleurs (rifampicine)</li><li>recherche grossesse (pyrazinamide)</li></ul></div></div></div></foreignObject><text x="105" y="2399" fill="#000000" font-family="Karla" font-size="12px">Le bilan pré-thérapeutique comprend :...</text></switch></g><rect x="20" y="1190" width="760" height="500" fill="none" stroke="#000000" pointer-events="all"/><rect x="20" y="120" width="760" height="950" fill="none" stroke="#000000" pointer-events="all"/><rect x="0" y="100" width="80" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 115px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Introduction</div></div></div></foreignObject><text x="40" y="119" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">Introduction</text></switch></g><rect x="90" y="140" width="690" height="250" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 708px; height: 1px; padding-top: 132px; margin-left: 72px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>maladie transmissible liée à <b>Mycobacterium tuberculosis</b> (= BK), parfois M. bovis ou M. africanum<br /></li><li><b>BAAR aérobie stricte</b> à croissance lente et à multiplication intra- et extra-cellulaire</li><li>Localisation <b>pulmonaire </b>dans 75%</li><li>chez l'imD : 50% localisations extra-pulmonaires, 25% disséminé, symptômes plus légers</li><li>France </li><ul><li>faible incidence : 7.5/100 000/an = 5000 cas/an</li><li>surtout IDF, Mayotte, Guyane, migrants d'Afrique subsaharienne, SDF</li><li>ALD pour 2 ans</li></ul><li>Monde</li><ul><li>10M cas/an avec 1.5M décès/an</li><li>F5 décès par maladie, F2 décès par maladie infectieuse<br /></li><li>6% sont des tuberculoses multi-résistantes (surtout ex-URSS, Chine, Inde)</li></ul><li><span style="font-size: 12px">Le traitement cible 3 <b>populations de BK</b> :</span></li><ul><li><span style="font-size: 12px">extra-cellulaires (95%) : contagiosité et symptômes ; ssb INH, RMP et streptomycine</span></li><li><span style="font-size: 12px">intra-cellulaires quiescents ; ssb PZA et RMP</span></li><li><span style="font-size: 12px">extra-cellulaires dans le caséeum : rechute ; ssb RMP</span></li></ul></ul></div></div></div></foreignObject><text x="72" y="144" fill="black" font-family="Karla" font-size="12px">maladie transmissible liée à Mycobacterium tuberculosis (= BK), parfois M. bovis ou M. africanum...</text></switch></g><rect x="20" y="140" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 150px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">généralités</div></div></div></foreignObject><text x="55" y="154" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">généralités</text></switch></g><rect x="90" y="390" width="690" height="230" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 708px; height: 1px; padding-top: 382px; margin-left: 72px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ol><li style="font-size: 12px"><b>Contamination </b>: inhalation d'aérosols (gouttelettes de toux) atteignant les alvéoles (= <b style="font-size: 12px">foyer primaire</b>)</li><li style="font-size: 12px"><span style="font-size: 12px"><b>Primo-infection</b> (= PIT) souvent asymptomatique (= ITL = infection tuberculeuse latente)</span></li><ul style="font-size: 12px"><li style="font-size: 12px">BK phagocytés puis multipliés dans <b style="font-size: 12px">macrophages </b>alvéolaires puis gagnent le gg hilaire. Le <b>complexe primaire</b> <br style="font-size: 12px" />est l'association foyer primaire + adénopathie, pouvant rester visible en RXT pendant des années</li><li style="font-size: 12px">Dans les semaines qui suivent la PIT : <b>réponse immune</b> avec afflux des monocytes épithélioïdes formant les <b>granulomes </b>giganto-cellulaires avec nécrose caséeuse contenant des bacilles quiescents. </li><li style="font-size: 12px">L'ITL est parfois patente avec AEG, érythème noueux, kérato-conjonctivite phlycténulaire, adn cervicales. </li></ul><li><span style="font-size: 12px"><b>Tuberculose maladie</b> (= TM) : multiplication des BK (pendant ou après ITL)</span></li><ul><li><span style="font-size: 12px">5% des ITL font une TM &lt; 2 ans post-PIT, 5% font une TM &gt; 2 ans post-PIT</span></li><li>fris de TM :</li><ul><li>diabète, InRé</li><li>imD, âges extrêmes, malnutrition, précarité</li><li>alcool, tabac, toxicomanie</li></ul></ul></ol><div><span style="color: rgba(0 , 0 , 0 , 0) ; font-family: monospace ; font-size: 0px">%3CmxGraphModel%3E%3Croot%3E%3CmxCell%20id%3D%220%22%2F%3E%3CmxCell%20id%3D%221%22%20parent%3D%220%22%2F%3E%3CmxCell%20id%3D%222%22%20value%3D%22%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3B3%26amp%3Bnbsp%3Bpopulations%26amp%3Bnbsp%3Bde%20BK%20sont%20%C3%A0%20cibler%20%3A%26lt%3Bbr%26gt%3B%26lt%3B%2Ffont%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bextra-cellulaires%20(95%25)%20%3A%20contagiosit%C3%A9%20et%20sympt%C3%B4mes%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20INH%2C%20RMP%20et%20streptomycine%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bintra-cellulaires%20quiescents%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bspan%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20PZA%20et%20RMP%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fspan%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3B%26lt%3Bspan%26gt%3Bextra-cellulaires%20dans%20le%20cas%C3%A9eum%20%3A%20rechute%26lt%3B%2Fspan%26gt%3B%26lt%3Bbr%26gt%3B%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Bfont-family%3A%20%26amp%3B%2334%3Bkarla%26amp%3B%2334%3B%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20RMP%26lt%3B%2Fspan%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3B%2Ful%26gt%3B%22%20style%3D%22text%3Bhtml%3D1%3B%22%20vertex%3D%221%22%20parent%3D%221%22%3E%3CmxGeometry%20x%3D%22120%22%20y%3D%22560%22%20width%3D%22430%22%20height%3D%22120%22%20as%3D%22geometry%22%2F%3E%3C%2FmxCell%3E%3C%2Froot%3E%3C%2FmxGraphModel%3E</span><br /></div></div></div></div></foreignObject><text x="72" y="394" fill="#000000" font-family="Karla" font-size="12px">Contamination : inhalation d'aérosols (gouttelettes de toux) atteignant les alvéoles (= foyer primaire)Primo-infection...</text></switch></g><rect x="20" y="390" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 405px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">histoire naturelle</div></div></div></foreignObject><text x="55" y="409" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">histoire na...</text></switch></g><rect x="100" y="0" width="600" height="80" fill="none" stroke="#000000" transform="translate(2,3)" opacity="0.25"/><rect x="100" y="0" width="600" height="80" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 598px; height: 1px; padding-top: 40px; margin-left: 101px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><font style="font-size: 30px">155 - Tuberculose</font></div></div></div></foreignObject><text x="400" y="44" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">155 - Tuberculose</text></switch></g><rect x="90" y="1210" width="690" height="70" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 1202px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>signes cliniques évoluant depuis des semaines ou des mois</li><li>RXT : nodules, infiltrats ou <b>cavernes </b>des lobes supérieurs et postérieurs</li><li>contexte évocateur : contage, voyage, CSP, imD</li><li>dès la suspicion, <b>isolement "air"</b> jusqu'à 15 jours de ttt</li></ul></div></div></div></foreignObject><text x="77" y="1214" fill="black" font-family="Karla" font-size="12px">signes cliniques évoluant depuis des semaines ou des moisRXT : nodules, infiltrats ou cavernes des lobes supérieurs e...</text></switch></g><rect x="20" y="1210" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1220px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">suspicion</div></div></div></foreignObject><text x="55" y="1224" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">suspicion</text></switch></g><rect x="20" y="1300" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1315px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">diagnostic<br />positif</div></div></div></foreignObject><text x="55" y="1319" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">diagnostic...</text></switch></g><rect x="88" y="1300" width="690" height="240" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 683px; height: 1px; padding-top: 1307px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><font><b>3 prélèvements</b> en 24h :<br /><ul><li><font><b>ECBC </b>en mycobactériologie (recherche de BAAR)</font></li><ul><li><font>si le patient ne crache pas, <b>tubage gastrique</b> le matin à jeun avant le lever</font></li></ul><li>si échec (3 prélèvements négatifs)</li><ul><li>fibroscopie bronchique avec aspiration dirigée <b style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">± </b><span style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">LBA</span></li></ul><li><span style="font-size: 12px">si miliaire</span></li><ul><li><span style="font-size: 12px">fibroscopie bronchique avec aspiration dirigée </span><b style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">± </b><span style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">LBA</span></li><li><font color="#202122"><span style="font-size: 12px">hémoc sur milieu isolator</span></font></li><li><font color="#202122"><span style="font-size: 12px">ECBU en mycobactériologie</span></font></li><li><font color="#202122"><span style="font-size: 12px">si leuco-neutropénie : myéloculture</span></font></li></ul><li><span style="color: rgb(32 , 33 , 34)">si extra-pulmonaire :</span><br /></li><ul><li><span style="color: rgb(32 , 33 , 34)">ganglionnaire : ponction ou biopsie-exérèse d'adénopathie accessible</span></li><li><span style="color: rgb(32 , 33 , 34)">neuro-méningée : PL</span></li><li><span style="color: rgb(32 , 33 , 34)">génito-urinaire : ECBU 3 jours de suite</span></li></ul></ul></font></div></div></div></foreignObject><text x="95" y="1319" fill="#000000" font-family="Karla" font-size="12px">3 prélèvements en 24h :...</text></switch></g><rect x="20" y="1540" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1550px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">analyse</div></div></div></foreignObject><text x="55" y="1554" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">analyse</text></switch></g><rect x="90" y="1540" width="690" height="150" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 1532px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>examen direct : recherche BAAR (coloration Ziehl-Neelsen) en qq heures ; positive ssi &gt; 10<sup>3</sup><span> bacilles/mL. Répéter les prélèvements si examen direct négatif (n'élimine pas le diagnostic)</span></li><li><span>anapath : granulome épithélioïde gigantocellulaire avec nécrose caséeuse (très évocateur mais non pathognomonique)</span></li><li>culture sur milieux enrichis</li><ul><li>milieu solide (Löwenstein-Jensen) en 3-4 semaines</li><li>milieu liquide en 10-15 jours mais doit être reconfirmé par examen direct</li></ul><li><span style="font-size: 12px">identification (M. tuberculosis ou atypique) par biochimie, culture ou PCR</span></li><li>ATBg obligatoire (2% de MDR : résistent à RMP et INH)</li></ul></div></div></div></foreignObject><text x="77" y="1544" fill="black" font-family="Karla" font-size="12px">examen direct : recherche BAAR (coloration Ziehl-Neelsen) en qq heures ; positive ssi &gt; 103 bacilles/mL. Répéter les...</text></switch></g><rect x="0" y="1170" width="80" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 1185px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Diagnostic</div></div></div></foreignObject><text x="40" y="1189" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">Diagnostic</text></switch></g><rect x="20" y="620" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 635px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">localisations</div></div></div></foreignObject><text x="60" y="639" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">localisations</text></switch></g><rect x="100" y="620" width="680" height="350" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 627px; margin-left: 107px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Les formes <b>pulmonaires </b>représentent <b>75%</b> des cas<br /><ul><li><b>Tuberculose pulmonaire commune</b> (la plus classique)</li><ul><li>pas de st spécifique : signes généraux, respiratoires (voire pleural)</li><li>lésions des segments postérieurs des lobes supérieurs (PO2 plus élevée : BK aérobie strict)</li><li>3 types de lésions pouvant s'associer : nodules, infiltrats et cavernes</li></ul><li><span style="font-size: 12px"><b>Miliaire </b>tuberculeuse</span></li><ul><li><span style="font-size: 12px">dissémination hématogène, généralisée, évolution svt défavorable : doit être pec rapidement</span></li><li><span style="font-size: 12px">PID micronodulaire en "grains de mil" bilatérale (parfois lésions macro-nodulaires si forme évoluée)</span></li></ul><li><span style="font-size: 12px"><b>Pleurésie </b>tuberculeuse</span></li><ul><li>épanchement exsudatif et lymphocytaire, unilatéral</li><li>examen direct positif dans &lt; 10%, culture (liquide ou biopsie) positive dans &lt; 30%, anapath de biopsies pleurales positives dans &gt; 80%</li></ul><li><span style="font-size: 12px"><b>Pneumonie aigüe</b> tuberculeuse</span></li><ul><li><span style="font-size: 12px">forme aigüe rare : ensemencement massif de BK sur lésion excavée avec inflammation intense</span></li><li><span style="font-size: 12px">RXT : comme PAC avec petites excavations</span></li></ul></ul><div>Les formes <b>extra-pulmonaires</b> représentent <b>25%</b> des cas, peuvent toucher tous les organes, mais surtout :</div><div><ul><li>gg (50% des formes extra-pulmonaires) : surtout cervicale et médiastinale</li><li>ostéo-articulaire : surtout spondylodiscite tuberculeuse (= mal de Pott)</li><li>génito-urinaire</li><li>neuro-méningée</li></ul></div></div></div></div></foreignObject><text x="107" y="639" fill="#000000" font-family="Karla" font-size="12px">Les formes pulmonaires représentent 75% des cas...</text></switch></g><rect x="20" y="970" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 985px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">vaccin</div></div></div></foreignObject><text x="60" y="989" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">vaccin</text></switch></g><rect x="100" y="970" width="680" height="80" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 693px; height: 1px; padding-top: 962px; margin-left: 87px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>Le vaccin n'est plus obligatoire depuis 2007, mais conseillé pour les enfants à haut risque</li><li>Administration le plus tôt possible</li><li>Pas de test tuberculinique préalable si nourrisson &lt; 3 mois, mais nécessaire jusqu'à 15 ans</li><li>CI si suspicion VIH ou imD (risque <b>BCGite disséminée</b> potentiellement létale)</li></ul></div></div></div></foreignObject><text x="87" y="974" fill="#000000" font-family="Karla" font-size="12px">Le vaccin n'est plus obligatoire depuis 2007, mais conseillé pour les enfants à haut risqueAdministration le plus tô...</text></switch></g><rect x="20" y="2380" width="78" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 76px; height: 1px; padding-top: 2395px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">bilans</div></div></div></foreignObject><text x="59" y="2399" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">bilans</text></switch></g><rect x="20" y="2780" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 2795px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">traitement</div></div></div></foreignObject><text x="55" y="2799" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">traitement</text></switch></g><rect x="88" y="2780" width="680" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 2787px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">En général 6 mois : <b>quadrithérapie 2 mois</b> puis <b>bithérapie 4 mois<br /></b></div></div></div></foreignObject><text x="95" y="2799" fill="#000000" font-family="Karla" font-size="12px">En général 6 mois : quadrithérapie 2 mois puis bithérapie 4 mois&#xa;</text></switch></g><rect x="20" y="2530" width="88" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 86px; height: 1px; padding-top: 2540px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">médicaments</div></div></div></foreignObject><text x="64" y="2544" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">médicaments</text></switch></g><rect x="0" y="2340" width="60" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 2355px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">TM</div></div></div></foreignObject><text x="30" y="2359" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">TM</text></switch></g><path d="M 218 2810 L 215.5 2810 Q 213 2810 213 2820 L 213 2827.5 Q 213 2835 210.5 2835 L 209.25 2835 Q 208 2835 210.5 2835 L 211.75 2835 Q 213 2835 213 2845 L 213 2852.5 Q 213 2860 215.5 2860 L 218 2860" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 268 2810 L 265.5 2810 Q 263 2810 263 2820 L 263 2827.5 Q 263 2835 260.5 2835 L 259.25 2835 Q 258 2835 260.5 2835 L 261.75 2835 Q 263 2835 263 2845 L 263 2852.5 Q 263 2860 265.5 2860 L 268 2860" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,263,2835)" pointer-events="all"/><rect x="218" y="2810" width="40" height="50" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2835px; margin-left: 219px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br />PZA<br />EMB</div></div></div></foreignObject><text x="238" y="2839" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><rect x="361" y="2810" width="40" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2825px; margin-left: 362px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br /></div></div></div></foreignObject><text x="381" y="2829" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 411 2810 L 408.5 2810 Q 406 2810 406 2817.5 L 406 2821.25 Q 406 2825 403.5 2825 L 402.25 2825 Q 401 2825 403.5 2825 L 404.75 2825 Q 406 2825 406 2832.5 L 406 2836.25 Q 406 2840 408.5 2840 L 411 2840" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,406,2825)" pointer-events="all"/><path d="M 361 2810 L 358.5 2810 Q 356 2810 356 2817.5 L 356 2821.25 Q 356 2825 353.5 2825 L 352.25 2825 Q 351 2825 353.5 2825 L 354.75 2825 Q 356 2825 356 2832.5 L 356 2836.25 Q 356 2840 358.5 2840 L 361 2840" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="88" y="2890" width="680" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 2897px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Si CI PZA : <b>trithérapie 3 mois </b>puis <b>bithérapie 6 mois</b></div></div></div></foreignObject><text x="95" y="2909" fill="#000000" font-family="Karla" font-size="12px">Si CI PZA : trithérapie 3 mois puis bithérapie 6 mois</text></switch></g><rect x="158" y="2920" width="40" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2940px; margin-left: 159px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br />EMB</div></div></div></foreignObject><text x="178" y="2944" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 158 2920 L 155.5 2920 Q 153 2920 153 2930 L 153 2935 Q 153 2940 150.5 2940 L 149.25 2940 Q 148 2940 150.5 2940 L 151.75 2940 Q 153 2940 153 2950 L 153 2955 Q 153 2960 155.5 2960 L 158 2960" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 208 2920 L 205.5 2920 Q 203 2920 203 2930 L 203 2935 Q 203 2940 200.5 2940 L 199.25 2940 Q 198 2940 200.5 2940 L 201.75 2940 Q 203 2940 203 2950 L 203 2955 Q 203 2960 205.5 2960 L 208 2960" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,203,2940)" pointer-events="all"/><rect x="288" y="2920" width="40" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2935px; margin-left: 289px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br /></div></div></div></foreignObject><text x="308" y="2939" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 288 2920 L 285.5 2920 Q 283 2920 283 2927.5 L 283 2931.25 Q 283 2935 280.5 2935 L 279.25 2935 Q 278 2935 280.5 2935 L 281.75 2935 Q 283 2935 283 2942.5 L 283 2946.25 Q 283 2950 285.5 2950 L 288 2950" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 338 2920 L 335.5 2920 Q 333 2920 333 2927.5 L 333 2931.25 Q 333 2935 330.5 2935 L 329.25 2935 Q 328 2935 330.5 2935 L 331.75 2935 Q 333 2935 333 2942.5 L 333 2946.25 Q 333 2950 335.5 2950 L 338 2950" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,333,2935)" pointer-events="all"/><path d="M 648 2900 L 648 2899.47 L 658 2900 L 668 2900.58 L 678 2900.38 L 688 2900.32 L 698 2899.7 L 708 2900.47 L 718 2899.86 L 728 2900.46 L 738 2899.51 L 748 2899.87 L 758 2900 L 757.95 2900 L 758.02 2908 L 758.1 2916 L 757.81 2924 L 758.01 2932 L 758 2940 L 758 2940.2 L 748 2939.29 L 738 2940.45 L 728 2939.72 L 718 2939.75 L 708 2939.41 L 698 2939.62 L 688 2939.36 L 678 2940.26 L 668 2939.29 L 658 2939.81 L 648 2940 L 647.94 2940 L 648.16 2932 L 648.19 2924 L 648.08 2916 L 647.8 2908 L 648 2900 L 648 2900 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2920px; margin-left: 649px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Les ATB sont à adapter selon l'ATBg</div></div></div></foreignObject><text x="703" y="2924" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">Les ATB sont à ada...</text></switch></g><rect x="108" y="2530" width="672" height="290" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 665px; height: 1px; padding-top: 2537px; margin-left: 115px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Les anti-tuberculeux utilisés en <b>1e intention</b> sont :</div><ul><li><b>Isoniazide </b>= INH (RIMIFON)</li><ul><li>EI : <b>hépatite</b>, polynévrite sst-mot si carence B6</li></ul><li><b>Rifampicine </b><span>= RMP (RIMACTAN, RIFADINE)</span><br /></li><ul><li><b>colore en orange</b><span> les larmes, sperme et urines (normal mais prévenir)</span><br /></li><li>intéractions : anticoagulants oraux, pilule oestro-progestative (à changer car rend inefficace), inhibiteurs de protéase, CTC, digitaliques</li></ul><li><span style="font-size: 12px"><b>Pyrazinamine </b>= PZA (PIRILENE)</span></li><ul><li><span style="font-size: 12px">CI si InHep ou InRé, déconseillée si grossesse</span></li><li><span style="font-size: 12px">EI : <b>cytolyse hépatique</b> (plus tardif que INH), hyperuricémie svt ast, rash vasomoteur</span></li></ul><li><span style="font-size: 12px"><b>Ethambutol</b> = EMB (MYAMBUTOL, DEXAMBUTOL)</span></li><ul><li><span style="font-size: 12px">EI : <b>névrite optique rétrobulbaire</b> (fris : posologie élevée, éthylisme chronique, InRé)</span></li></ul></ul><div>En <b>2e intention</b>, si tuberculose MDR, on peut utiliser des <b>FQ </b>et <b>aminosides </b>(streptomycine, amikacine : toxicités rénale et auditive)</div></div></div></div></foreignObject><text x="115" y="2549" fill="black" font-family="Karla" font-size="12px">Les anti-tuberculeux utilisés en 1e intention sont :...</text></switch></g><path d="M 428 2500 L 428 2380" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 648 2780 L 648 2779.82 L 658 2780.52 L 668 2779.48 L 678 2779.85 L 688 2779.75 L 698 2779.29 L 708 2779.71 L 718 2779.67 L 728 2780.53 L 738 2779.51 L 748 2780.52 L 758 2780 L 757.67 2780 L 758.2 2790 L 757.9 2800 L 757.27 2810 L 757.53 2820 L 758 2830 L 758 2830.3 L 748 2830.66 L 738 2829.6 L 728 2829.79 L 718 2829.44 L 708 2829.73 L 698 2829.33 L 688 2829.26 L 678 2830.61 L 668 2830.74 L 658 2830.08 L 648 2830 L 648.12 2830 L 648.4 2820 L 647.86 2810 L 647.67 2800 L 648.26 2790 L 648 2780 L 648 2780 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2805px; margin-left: 649px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">si neuro-méningée : durée de 9-12 mois</div></div></div></foreignObject><text x="703" y="2809" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">si neuro-méningée...</text></switch></g><path d="M 638 2840 L 638 2840.44 L 648 2839.75 L 658 2839.39 L 668 2839.28 L 678 2839.36 L 688 2839.56 L 698 2839.6 L 708 2839.38 L 718 2840.04 L 728 2840.66 L 738 2839.61 L 748 2839.35 L 758 2840 L 758.35 2840 L 758.65 2850 L 758.02 2860 L 757.66 2870 L 758.11 2880 L 758 2890 L 758 2889.59 L 748 2889.7 L 738 2890.07 L 728 2890.35 L 718 2890.1 L 708 2890.43 L 698 2889.72 L 688 2889.31 L 678 2889.6 L 668 2890.7 L 658 2889.44 L 648 2890.39 L 638 2890 L 638.22 2890 L 638.4 2880 L 638.08 2870 L 637.67 2860 L 638.01 2850 L 638 2840 L 638 2840 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 118px; height: 1px; padding-top: 2865px; margin-left: 639px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">si miliaire très sévère : ajout CTC</div></div></div></foreignObject><text x="698" y="2869" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">si miliaire très sév...</text></switch></g><rect x="90" y="1780" width="690" height="170" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 683px; height: 1px; padding-top: 1787px; margin-left: 97px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px">Les 2 moyens de dépister les ITL sont :</div><div style="font-size: 12px"><ul style="font-size: 12px"><li style="font-size: 12px"><b style="font-size: 12px">IDR </b>(= intradermoréaction) = RCT (= réaction cutanée tuberculinique) </li><ul style="font-size: 12px"><li style="font-size: 12px">interprétation difficile si vaccin BCG &lt; 10 ans car se positive avec M. bovis</li><li style="font-size: 12px">lecture à 72h : IDR positive si induration &gt; 5 mm</li><li style="font-size: 12px">suspicion ITL si <b style="font-size: 12px">&gt; 10 mm sans BCG</b> ou augmentation<b style="font-size: 12px"> 10 mm entre 2 IDR en 3 mois</b></li></ul><li style="font-size: 12px"><b style="font-size: 12px">IGRA </b>(détection de production d'<span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">IFN</span><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">-</span><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">γ) par prise de sang</span></li><ul style="font-size: 12px"><li style="font-size: 12px"><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">meilleure VPP que l'IDR (osef BCG)</span></li><li style="font-size: 12px"><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">résultats après qq jours</span></li></ul></ul></div></div></div></div></foreignObject><text x="97" y="1799" fill="black" font-family="Karla" font-size="12px">Les 2 moyens de dépister les ITL sont :...</text></switch></g><path d="M 598 1210 L 598 1210.2 L 608 1210.32 L 618 1210.13 L 628 1209.6 L 638 1210.25 L 648 1210.05 L 658 1209.96 L 668 1210.05 L 678 1210.69 L 688 1209.6 L 698 1210.74 L 708 1209.84 L 718 1209.27 L 728 1210.43 L 738 1210.39 L 748 1210.46 L 758 1210 L 758.5 1210 L 758.31 1220 L 758.68 1230 L 758.37 1240 L 757.28 1250 L 758.31 1260 L 758 1270 L 758 1269.41 L 748 1269.86 L 738 1269.38 L 728 1269.31 L 718 1270.62 L 708 1270.73 L 698 1270.03 L 688 1270.46 L 678 1269.52 L 668 1269.46 L 658 1269.8 L 648 1270.41 L 638 1270.47 L 628 1269.64 L 618 1270.07 L 608 1269.76 L 598 1270 L 597.95 1270 L 598.27 1260 L 597.98 1250 L 598.07 1240 L 597.53 1230 L 598.55 1220 L 598 1210 L 598 1210 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 158px; height: 1px; padding-top: 1240px; margin-left: 600px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"><span>Déclaration ARS :</span></div>- ITL d'enfant &lt; 15 ans<br />- TM confirmée ou suspectée</div></div></div></foreignObject><text x="600" y="1244" fill="#000000" font-family="Pangolin" font-size="12px">Déclaration ARS :- ITL d'e...</text></switch></g><rect x="0" y="1740" width="60" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 1755px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">ITL</div></div></div></foreignObject><text x="30" y="1759" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ITL</text></switch></g><rect x="20" y="1780" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1790px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">dépistage</div></div></div></foreignObject><text x="55" y="1794" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">dépistage</text></switch></g><rect x="228" y="1950" width="60" height="20" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 1960px; margin-left: 229px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">contact</div></div></div></foreignObject><text x="258" y="1964" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">contact</text></switch></g><path d="M 243 1970 L 210.64 1987.03" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 205.99 1989.48 L 210.55 1983.12 L 210.64 1987.03 L 213.81 1989.32 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 273 1970 L 294.88 1986.21" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 299.1 1989.33 L 291.39 1987.98 L 294.88 1986.21 L 295.56 1982.36 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 180.02 2020 L 180.15 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 180.16 2138.88 L 176.65 2131.89 L 180.15 2133.63 L 183.65 2131.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="130" y="1990" width="100" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 98px; height: 1px; padding-top: 2005px; margin-left: 132px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">- enfant &lt; 2 ans<br />- imD sévère</div></div></div></foreignObject><text x="132" y="2009" fill="#000000" font-family="Karla" font-size="12px">- enfant &lt; 2 ans...</text></switch></g><rect x="130" y="2140" width="380" height="70" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe center; width: 378px; height: 1px; padding-top: 2147px; margin-left: 131px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">CHIMIOPROPHYLAXIE</div></div></div></foreignObject><text x="320" y="2159" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">CHIMIOPROPHYLAXIE</text></switch></g><rect x="280" y="1990" width="80" height="50" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 78px; height: 1px; padding-top: 2015px; margin-left: 282px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">- répété<br />- rapproché<br />- fragile</div></div></div></foreignObject><text x="282" y="2019" fill="#000000" font-family="Karla" font-size="12px">- répété...</text></switch></g><rect x="370" y="1975" width="190" height="60" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 188px; height: 1px; padding-top: 2005px; margin-left: 372px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"></div><font style="font-size: 12px">- avant ttt <span style="color: rgb(34 , 34 , 34) ; background-color: rgb(255 , 255 , 255) ; font-size: 12px">anti-TNFα<br /></span>- bilan VIH<br />- pro. santé<br />- migrants &lt; 15 ans forte endémie<br /></font></div></div></div></foreignObject><text x="372" y="2009" fill="#000000" font-family="Karla" font-size="12px">- avant ttt anti-TNFα...</text></switch></g><path d="M 320 2090 L 320 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 320 2138.88 L 316.5 2131.88 L 320 2133.63 L 323.5 2131.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="280" y="2060" width="80" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 2075px; margin-left: 281px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div><b>IDR ou IGRA</b><br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="320" y="2079" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">IDR ou IGRA&#xa;</text></switch></g><path d="M 320 2040 L 320 2053.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 320 2058.88 L 316.5 2051.88 L 320 2053.63 L 323.5 2051.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 465 2035 L 465 2058.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 465 2063.88 L 461.5 2056.88 L 465 2058.63 L 468.5 2056.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="340" y="2170" width="170" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 168px; height: 1px; padding-top: 2190px; margin-left: 341px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">bithérapie 3-4 mois<br /><div><span style="font-size: 14px ; font-weight: 400 ; background-color: rgb(255 , 255 , 255)">(INH + RMP)</span></div></div></div></div></foreignObject><text x="425" y="2194" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">bithérapie 3-4 mois...</text></switch></g><rect x="300" y="2170" width="40" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2180px; margin-left: 301px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; "><span style="font-weight: normal">ou</span></div></div></div></foreignObject><text x="320" y="2184" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">ou</text></switch></g><rect x="130" y="2170" width="170" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 168px; height: 1px; padding-top: 2190px; margin-left: 131px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">monothérapie 6-9 mois<br /><span style="font-weight: normal">(INH)</span></div></div></div></foreignObject><text x="215" y="2194" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">monothérapie 6-9 mois...</text></switch></g><rect x="125" y="2065" width="110" height="30" fill="#ffffff" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2080px; margin-left: 126px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">ne pas attendre la<br />confirmation d'ITL</div></div></div></foreignObject><text x="180" y="2084" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ne pas attendre la...</text></switch></g><path d="M 465.02 2085 L 465.14 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 465.16 2138.88 L 461.64 2131.89 L 465.14 2133.63 L 468.64 2131.87 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="445" y="2065" width="40" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2075px; margin-left: 446px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div><b>IGRA</b><br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="465" y="2079" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">IGRA&#xa;</text></switch></g><rect x="396" y="1950" width="100" height="20" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 98px; height: 1px; padding-top: 1960px; margin-left: 398px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"></div><font style="font-size: 12px"><b>autres situations</b><br /></font></div></div></div></foreignObject><text x="398" y="1964" fill="#000000" font-family="Karla" font-size="12px">autres situation...</text></switch></g><rect x="377" y="2100" width="210" height="20" fill="#ffffff" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 208px; height: 1px; padding-top: 2110px; margin-left: 378px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div>ssi &lt; 18 ans, imD ou ITL récent (&lt; 1 an)<br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="482" y="2114" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ssi &lt; 18 ans, imD ou ITL récent (&lt;...</text></switch></g><rect x="20" y="1950" width="50" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 48px; height: 1px; padding-top: 1960px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">CAT</div></div></div></foreignObject><text x="45" y="1964" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">CAT</text></switch></g><rect x="20" y="2990" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 3005px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">cas particuliers</div></div></div></foreignObject><text x="55" y="3009" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">cas particu...</text></switch></g><rect x="90" y="2990" width="690" height="210" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 2982px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>grossesse</li><ul><li>supplémenter en B6 (INH), K1 (RMP)</li><li>en France, PZA déconseillée pendant grossesse et allaitement</li></ul><li>InRé</li><ul><li>clairance &gt; 30 : ttt normal</li><li>clairance = 15-30 : diminuer EMB, PZA</li><li>clairance &lt; 15 ou dialyse : diminuer INH, EMB, PZA</li></ul><li><span style="font-size: 12px">InHep</span></li><ul><li><span style="font-size: 12px">transaminases = 3-6N asymptomatique : arrêt PZA (peut être repris si retour à la normale)</span></li><li><span style="font-size: 12px">transaminases &gt; 6N ou symptomatique : arrêt INH et PZA voire du ttt antituberculeux</span></li></ul><li><span style="font-size: 12px">tuberculoses multi-résistantes</span></li><ul><li><span style="font-size: 12px">MDR (résiste INH et RMP) : représente 2% des tuberculoses en France, ttt de 2e intention (aminosides, FQ)</span></li><li><span style="font-size: 12px">XDR (résiste INH et RMP + FQ + 1 ttt de 2e intention) : très mortelle mais exceptionnelle en France</span></li></ul></ul></div></div></div></foreignObject><text x="77" y="2994" fill="#000000" font-family="Karla" font-size="12px">grossesse...</text></switch></g><path d="M 603 1310 L 603 1310.08 L 613 1309.26 L 623 1310.14 L 633 1310.27 L 643 1309.97 L 653 1309.76 L 663 1310.44 L 673 1310.05 L 683 1310.58 L 693 1309.98 L 703 1309.47 L 713 1309.73 L 723 1310.15 L 733 1309.74 L 743 1309.4 L 753 1310 L 753.54 1310 L 752.57 1320 L 752.78 1330 L 752.35 1340 L 752.28 1350 L 753 1360 L 753 1360 L 743 1360.06 L 733 1359.78 L 723 1360.62 L 713 1359.87 L 703 1360.35 L 693 1360.51 L 683 1360.2 L 673 1360.16 L 663 1360.19 L 653 1360.71 L 643 1360.5 L 633 1360.69 L 623 1359.26 L 613 1360.63 L 603 1360 L 602.57 1360 L 602.91 1350 L 602.92 1340 L 602.95 1330 L 603.36 1320 L 603 1310 L 603 1310 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 148px; height: 1px; padding-top: 1335px; margin-left: 605px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Déclaration CLAT nominatif pour enquête autour du cas<br /><div style="text-align: center"></div></div></div></div></foreignObject><text x="605" y="1339" fill="#000000" font-family="Pangolin" font-size="12px">Déclaration CLAT nominati...</text></switch></g><rect x="668" y="1280" width="20" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 18px; height: 1px; padding-top: 1290px; margin-left: 669px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 19px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">+</div></div></div></foreignObject><text x="678" y="1296" fill="#000000" font-family="Pangolin" font-size="19px" text-anchor="middle">+</text></switch></g></g><switch><g requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"/><a transform="translate(0,-5)" xlink:href="https://desk.draw.io/support/solutions/articles/16000042487" target="_blank"><text text-anchor="middle" font-size="10px" x="50%" y="100%">Viewer does not support full SVG 1.1</text></a></switch></svg>